Now the AdnaTest portfolio covers all the leading cancers that impact people's lives.
Circulating tumor cells (CTCs) are important in tumor dissemination. Molecular characterization of CTCs isolated from liquid biopsies provides insight into the biology of tumors cells, new molecular pathways, relevant biomarkers, the mechanisms of cancer progression and even tumor therapy resistance. QIAGEN's new AdnaTest LungCancer and ProstateCancerPanel AR-V7 Kits can give you added insights that may help you make your next big discovery!
AdnaTest ProstateCancerPanel AR-V7 Kit
The new AdnaTest ProstateCancerPanel AR-V7 detects splice variant AR-V7, an essential marker for prostate cancer therapy resistance to Arbiraterone and Enzalutamide. This kit uses a immunomagnetic cell-selection system to enrich circulating tumor cells from human blood and to detect prostate cancer-associated genes including AR-V7 by real-time PCR. Get a highly specific selection of CTCs, highly sensitive
Learn more
detection of a mix of prostate cancer associated targets
including AR-V7 splice variant and enjoy standardized, reproducible and accurate results!
AdnaTest LungCancer Kit
The new AdnaTest LungCancer Kit, can provide unique insights into the molecular mechanisms of lung cancer through a highly specific selection of CTCs, in combination with a sensitive detection of a mix of lung-cancer associated targets. This kit detects EMT, an important marker of cancer therapy resistance, and specifically selects CTCs against a high leukocyte background providing data that is easy to interpret. The kit is even flexible enough to accommodate detection of alternative or novel biomarkers. Get easy, fast, highly accurate and reliable disease status interpretation, using only 5 ml of blood, without the need of expensive instrumentation!
Find out more
New cancer discoveries with circulating tumor cells
CTCs can provide researchers with important new discoveries on the mechanism of cancer. Find out more about the latest technology that provides researchers the necessary tools to conduct CTC research in lung, breast, prostate, colon, ovarian cancers and EMT/cancer stem cells .
Gain new insights